DRUG-INDUCED CUTANEOUS LUPUS ERYTHEMATOSUS
Abstract
Statins are widely used nowadays. They are usually safe but sometimes can be associated with the development/ worsening of autoimmune diseases like Cutaneous Lupus Erythematosus. Authors describe the case of a female caucasian patient, 74 years-old, that 18 months after initiating therapy with simvastatin developed an annular skin rash on back and shoulders, characterized by erythematous papules and plaques with a desquamative surface. Laboratory tests showed positive ANA and anti-SSA antibodies. Skin biopsy was consistent with clinical diagnosis of Subacute Cutaneous Lupus Erythematosus. The clinical picture had complete resolution after Simvastatin cessation. Drug-induced Cutaneous Lupus Erythematosus is often very similar to idiopathic forms. Although it usually has a favorable prognosis, authors highlight its importance because of the possible associated systemic manifestations and disfiguring cutaneous scars.
Downloads
All articles in this journal are Open Access under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).